US › Healthcare

DocGo Inc (DCGO)

US · Healthcare · Medical Care Facilities

$0.37-1.97%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$73.4M

Revenue YoY

-8.7%

Net profit

$-15.8M

EPS

$0.16

EPS estimate

$-0.04

Net margin

-21.5%

EPS came in at 0.16 against a street estimate of -0.04 — a beat of 500.0%.

Key statistics

Market cap

$37.7M

Forward P/E

60.2

P/B

0.32

Book value

$1.20

EPS (TTM)

$-1.94

52-week high

$1.65

52-week low

$0.34

50-day MA

$0.54

200-day MA

$0.67

Beta

0.94

Analyst view

Analysts rate DocGo Inc a buy (4 buy, 3 hold, 0 sell out of 7) with an average price target of $1.88.

Shareholding

Insiders

3.06%

Institutions

39.04%

Largest institutional holders

Fund	Stake
BlackRock Inc	6.43%
Vanguard Capital Management, LLC	3.72%
P.a.w. Capital Corp	3.54%
Knott David M Jr	2.70%
Peapod Lane Capital LLC	2.53%
Citadel Advisors Llc	2.53%
Geode Capital Management, LLC	2.44%
S Squared Technology, LLC	2.08%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for DocGo Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.